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Abstract: Introduction: Acute Rheumatic Fever (ARF) is a multisystemic disease that results from 
an autoimmune reaction due to group A streptococcal infection. The disease affects predominantly 
children aged 5 to 15 years and although its incidence in developed Countries declined since the 
early 1900s, to date there is a paucity of data that confirm this epidemiological trend. Objective: The 
study aimed to assess the burden of ARF in term of hospitalization and to describe the characteristics 
of acute rheumatic fever (ARF) in the paediatric population of Lombardy. Study design: The study 
was carried out by analyzing hospital discharge records of patients resident of Lombardy and aged  
0–17 years old who, from 2014 to 2016, were hospitalized with the diagnosis of ARF. The following 
variables have been studied: age, sex, municipality of residence, date of diagnosis of each patient, 
hospital of admission, and presentation of the disease. Results: From 2014 to 2016, 215 patients were 
found to meet the inclusion criteria and diagnosed as affected from Acute Rheumatic Fever. The rate 
of hospitalization showed a slightly increasing trend from 3.42 in 2014 to about 5.0 in 2016. 
Moreover, ARF presented a typical seasonal trend with lower cases in the autumn and a peak of 
hospitalization in the spring. Conclusion: To date, ARF seems to be a rare but not negligible disease 
in southern central European countries, and in Lombardy we estimated an annual hospitalization rate 
of 4.24 cases per 100,000 children. The increasing trend found in our study suggests that the burden 
of the disease could be reduced by involving multidisciplinary health professionals who, in addition 
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to the paediatrician of free choice, would promote evidence based medicine management of the 
disease during all its clinical phases. 
Keywords: acute rheumatic fever; epidemiology; hospitalization; children; adolescent; 
paediatric; Italy 
 
1. Introduction 
Acute Rheumatic Fever (ARF) is a multisystemic disease that results from an autoimmune 
reaction due to group A streptococcal infection. It occurs mainly in school-age children and young 
adults [1]. The most common and specific clinical manifestations of the disease affect joints, heart, 
brain, cutaneous and subcutaneous, and include polyarthritis, carditis, chorea, appearance of 
subcutaneous nodules and erythema or rash [2]. The most significant complication is cardiac 
involvement, also defined as Rheumatoid Cardiopathy (RC). The most important of its heart clinical 
manifestations are largely characterised by valvulitis, involving in particular the mitral valve and 
aortic valve, with chronic and disabling consequences. 
Although the incidence and prevalence of ARF and RC are declining in developed Countries 
since the early 1900s, they continue to be the main causes of morbidity and mortality among young 
people in developing Countries. It has been estimated that there are over 15 million RC cases 
worldwide, with 282,000 new cases and 233,000 deaths each year [1]. Acute Rheumatic Fever 
affects predominantly children aged between 5 and 15 years of age. Initial episodes become less 
frequent in adolescents and young adults, and are rare in individuals over the age of 30; about 60% 
of people with ARF in endemic communities subsequently develop RC [3,4]. The risk of ARF is 
fundamentally overlapping in males and females, but the risk of rheumatic carditis is 1.6 to 2.0 
times higher in women [4,5]. The latest estimates of the global number of rheumatoid 
cardiovascular patients include 9 million years of life lost adjusted for disability, 33 million 
prevalent cases and 275,000 deaths each year, which occur predominantly in low and  
middle-income countries [6–8]. RC prevalence increases with age [9], depending on adherence to 
secondary prophylaxis, severity of valve damage, access to specialist management and  
surgery [10,11]. Acute Rheumatic Fever epidemiology varies from country to country [10], with a 
particularly high prevalence in Africa [12–14] and in the Pacific [15–18], in Latin America [19], 
the Middle East [20,21] and in Asia [22,23]. However, to date there is a paucity of updated data for 
several countries, including Italy. In this sense, updated data and both clinical and epidemiological 
characterization of the disease represent a major need for promoting preventive health strategies, 
quantifying national public health financial planning and, finally, reducing the burden of disease. 
According to the previous considerations, the main aim of this study was to examine the 
hospitalization rate attributable to ARF and describe its epidemiological characteristics in the 
paediatric population in Lombardy, the most populous region of Italy, during the 2014–2016 period. 
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2. Material and methods 
Lombardy is one of the twenty administrative regions of Italy; it is sited in the northwest of the 
country, with an area of 23,844 square kilometres (9,206 sq. mi) and about 10 million people 
(population of 10,023,876 to 1 January 2017 from ISTAT data), representing one-sixth of Italy’s 
population. Lombardy’s capital is the second-largest city and the largest metropolitan area in Italy. 
The study included a three-year timeframe, from January 1, 2014 to December 31, 2016. 
Subjects affected by ARF were identified by analysing hospital discharge records (HDRs) collected 
from all hospitals located in Italy and included in the Italian National Health Service. All data 
included in the analyses were obtained by the Italian Ministry of Health, which routinely collects 
HDRs from all the regions’ hospitals. According to the national laws and considering that data were 
provided as anonymous records, individual consent was not required. Each HDR included 
demographic information (residence, gender, and date of birth), admission and discharge dates, 
discharge status (categorized as “discharged/transferred” or “expired”), and up to 6 discharge 
diagnoses (1 principal and 5 secondary diagnoses) coded according to International Classification of 
Disease, Ninth Revision, Clinical Modification (ICD-9 CM). 
ARF cases were defined according to the following inclusion criteria: (a) occurrence of at 
least one ICD9-CM code of 390, 391.0, 391.1, 391.2, 391.8, 391.9, 392.0, 392.9, 393, 394.1, 395.0, 
395.1, 395.2, 397.1, 397.9, 398.0, 398.90, 398.91, 398.99 either as principal or secondary 
diagnosis; (b) age < 18 years old; (c) resident of Lombardy. Hospitalization of Lombardy residents 
that occurred outside the region was also included in the analysis, while multiple hospitalizations due 
to transfers were combined. Admissions for transferred patients were followed until discharge. The 
following variables have been analyzed: age, sex, municipality of residence, date of diagnosis of 
each patient, hospital of admission, and presentation of the disease. 
Statistical analyses were performed using the computing environment R (R Development Core 
Team, 2005) and maps were produced by ArcGIS (version 10.5.1 2016). Standard deviation was 
calculated for normally distributed quantitative variables. Hospitalization rates were calculated by 
dividing the number of hospitalizations by age cohort and then multiplying the quotient by 100,000. 
Two-sided P values and 95 percent confidence intervals were used to evaluate differences between 
males and females. 
3. Results 
From 2014 to 2016, 215 patients were found to meet the inclusion criteria and diagnosed as 
affected from Acute Rheumatic Fever. As reported in Table 1 and depicted in Figure 1, Milan was 
the first province for number of cases, accounting for 102 cases, followed by Varese: 22 cases, Como: 
17 cases, Monza Brianza: 16 cases, Bergamo: 15 cases, Brescia: 13 cases, Lecco: 12 cases, Pavia: 9 
cases, Lodi: 4 cases, Sondrio and Mantua (Mantova): 2 cases for province, and finally the Province 
of Cremona with only 1 case in three years. 
The hospitalization rate (cases/100,000 paediatric population) of ARF in Lombardy showed a 
slightly increasing trend from 2014 to 2016, from 3.42 cases in 2014 to about 5.0 cases in 2016. The 
mean age for patients was equal to 8.2 years (SD 3.1 years): 9.1 years in 2014, 10.3 years in 2015 
and 7.4 years in 2016. As reported in Figure 2, 30 patients were younger than 5 years of age, 
accounting for 14% of the total (215 in Lombardy residents). Hospitalization rates were not 
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statistically significantly different between males and females (4.45/100,000 vs. 4.30/100,000, 
respectively). Moreover, illness presented a typical seasonal trend with lower cases in autumn and 
then a steadily rises to its peak in April (Figure 3). 
In 2014, the highest number of hospitalizations were diagnosed with “Chorea Rheumatic 
without mention of Cardiac Complications” (20% of total admissions) and “Chorea Rheumatic with 
Cardiac Complications” (18%) followed by “Acute Rheumatoid Endocarditis” (15%) and 
“Rheumatic Fever without mention of Cardiac Involvement” (10%). 
In 2015, the diagnosis of “Acute Rheumatic Endocarditis” prevailed (17.7% of total admissions) 
followed by “Rheumatic Chorea without mention of Cardiac Complications” and “Rheumatic Fever 
without mention of Cardiac Involvement” (both 15.2%), and “Rheumatic Mitral Insufficiency” and 
“Unspecified acute Rheumatic Cardiac Disease” (12.7%). 
In 2016, most patients were diagnosed with “Acute Rheumatic Endocarditis” (23.8% of total 
admissions), “Rheumatic Fever without Cardiac Complications” (16.7%) and “Chorea Rheumatic 
with Cardiac Complications” (14.3%). 
Table 1. Summary of rates of incidence of paediatric Acute Rheumatic Fever per 100,000 residents. 
Province 
2014 2015 2016 2014–2016 
Population Cases 
Rate * 
100.000 
Population Cases 
Rate * 
100.000 
Population Cases 
Rate * 
100.000 
Population Cases 
Rate * 
100.000 
LECCO 58.572 4 6,83 57.979 5↑ 8,62↑ 57.389 3 5,23 173.940 12↑ 6,9↑ 
MILANO 529.174 25 4,72 527.147 44↑ 8,35↑ 529.011 33↑ 6,24↑ 1.585.332 102↑ 6,43↑ 
COMO 101.075 1 0,99 100.825 3 2,98 100.227 13↑ 12,97↑ 302.127 17↑ 5,63↑ 
VARESE 148.170 5 3,37 148.273 7 4,72 147.985 10↑ 6,76↑ 444.428 22 4,95 
PAVIA 82.862 5 6,03 82.762 1 1,21 82.497 3 3,64 248.121 9 3,63 
MONZA 
BRIANZA 
148.994 9 6,04 148.884 2 1,34 148.826 5 3,36 446.704 16 3,58 
LODI 39.094 0 0 39.021 1 2,56 38.867 3 7,72 116.982 4 3,42 
BERGAMO 203.630 4 1,96 202.890 2↓ 0,99↓ 201.212 9 4,47 607.732 15 2,47 
SONDRIO 30.247 0 0 29.880 1 3,35 29.561 1 3,38 89.688 2 2,23 
BRESCIA 228.002 3 1,32 226.986 7 3,08 225.196 3↓ 1,33↓ 680.184 13↓ 1,91↓ 
MANTUA 68.171 1 1,47 67.988 0↓ 0↓ 67.433 1 1,48 203.592 2↓ 0,98↓ 
CREMONA 57.783 1 1,73 57.492 0↓ 0↓ 57.115 0↓ 0↓ 172.390 1↓ 0,58↓ 
 
LOMBARDIA 1.695.774 58 3,42 1.690.127 73 4,32 1.685.319 84 4,98 5.071.220 215 4,24 
↑: high incidence rate by column, ↓: low incidence rate by column. 
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Figure 1. Geographic distribution of paediatric rheumatic cases in Lombardy (2014–2016). 
 
Figure 2. Number of hospital admissions divided by age and sex. 
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Figure 3. Number of hospital admissions divided by month of hospitalization in all patients 
(A) and in males vs females (B). 
4. Discussion 
Acute Rheumatic Fever (ARF) confirms to be still a current public health problem in Italy and 
to date it can be not considered a negligible disease in developed Countries. The real doubt is, 
therefore, if it can be considered a neglected disease. The question is difficult to answer but this 
study offers some findings that could help to clarify epidemiology of ARF among Italian paediatric 
population requiring hospitalization. A first finding of interest is that a significant number of 
paediatric ARF cases were recorded during each of all three years of the study, showing also an 
increasing trend from 2014 to 2016. We are well aware that three years are probably too short a 
period for evaluating trend but, noteworthy, there was no year without cases, suggesting that in 
Lombardy ARF shows to have the characteristics of an “endemic” disease with low incidence. 
Moreover, if the observed trend should be confirmed in future years, it would represent an inversion 
with respect to the past century when a decline in the incidence of acute rheumatic fever in 
developed countries has been observed as consequence of improved public hygiene and widespread 
use of antibiotics. To date, ARF seems to be a rare but not negligible disease not only in Lombardy, 
where we estimated about 4 cases per 100,000 children requiring hospitalization because of ARF or 
ARF complications, but also in other European countries. In this sense, our estimates are quite 
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similar to those observed in Abruzzo, another Italian region, in the period 2000–2009, where 88 
cases were found with an average annual incidence rate of 4.10 cases for 100,000 years-child [5]. 
Otherwise, the recent ARF outbreak in Slovenia revealed that the disease is still present in southern 
central Europe with an estimated annual incidence of 1.25 cases per 100,000 children [24]. These last 
data seem to be lower than those reported in our experience and in the other study previously cited 
and carried out in Abruzzo. The reasons for this difference could be attributed, at least in part, to the 
different study methods and we cannot exclude that some ARF cases reported in our study are not 
incident cases but prevalent ones. However, this hypothesis would explain only a limited part of the 
difference and further investigations may be required for clarifying these regional variations. 
Differently, no significant regional variations with respect to other studies were found in 
distribution of ARF complications. Our data showed that rheumatic carditis was the most frequent 
complication accounting for 61% of all diagnosis, which is similar to the other published data, in 
which it ranges from 45% to 95% [25,26]. Also the increase in the rate of hospitalization of 
patients with ARF, from March to July, with a peak in April and a second mild peak in November 
has been reported by other authors and it is in agreement with the seasonal variability of 
pharyngitis, which is caused by group A beta-haemolytic streptococci and is most often diagnosed 
in the winter and spring [27] or in the fall and winter [28,29]. Sydenham’s chorea was reported in 
26% of cases, although some authors observed rates to a minimum of 15–17% [30]. Some 
publications indicate rates of 6–31% and even 49% [31]. 
Finally, the mean age of patients with ARF in our study corresponds to the age reported by 
other authors [32]. Our study could be affected by some limitations that should be taken into account 
as the possibility that some ARF cases have not been hospitalized and thus not included in our 
analysis. Moreover, the lack of information about patient nationality could have underestimated the 
contribution of immigration in a region as Lombardy that, in the past decades, has received a very 
high number of people especially from Africa [12–14]. Unfortunately, the precise picture of the 
disease burden attributable to this microorganism is difficult to quantify, especially in contexts such 
as the Italian one, where ARF is not included among the diseases subject to notification. In such a 
context, hospital discharge databases may be the only way to understand, accurately and 
economically, the epidemiology of this disease. Despite these possible limitations, at our best 
knowledge this is the largest population study carried out in an Italian region. Two main messages 
come from our experience. The first is that ARF is a disease that cannot be considered eliminated in 
Lombardy and the second one is that, surprisingly, an increasing trend should stimulate further 
studies on this topic. 
5. Conclusion 
AFR is one of the main causes of heart disease among young people and it is still present in 
developing countries, but not only in these. In recent decades, there has been a new increase in ARF 
incidence in European countries and results obtained in the present study unquestionably agree with 
this datum. The increasing trend that we have found also suggests the needs for multidisciplinary, 
specialist, paediatric approach involving several professionals who, in addition to the paediatrician of 
free choice, promote evidence based medicine management of the disease during all phases of ARF. 
The involvement of the paediatrician is fundamental, both to prevent the disease and to follow the 
young patients affected by this disease. Every paediatrician should always bear in mind the risk of 
142 
AIMS Public Health Volume 5, Issue 2, 135–143. 
ARF and, therefore, should not underestimate even first symptoms attributable to a possible infection 
with group A beta-hemolytic Streptococcus. 
However, ARF management, which involves patients since their childhood, requires 
coordination, often throughout life, between prevention, diagnosis, treatment, psychological, 
rehabilitative and social assistance. For these reasons, it will be essential to develop appropriate tools 
for organization and communication in this area. 
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